Individual Stock News
1. Shouhui Group (02621.HK): Expects net profit of approximately RMB 780 million to RMB 800 million for 2025.
2. Hengrui Medicine (01276.HK): Received approval for clinical trials of its injectable drug SHR-9803.
3. China Metallurgical Group (01618.HK): New contract signings in the first two months totaled RMB 132.44 billion, a year-on-year decrease of 6.49%.
4. Xincheng Development (01030.HK): February contract sales amounted to approximately RMB 1.223 billion, a year-on-year decrease of 37.57%.
5. Yanchang Petroleum International (00346.HK) issued a profit warning: Expects a loss of approximately HKD 780 million in 2025, a reversal from profit to loss year-on-year.
6. Q Technology (01478.HK): February mobile phone camera module sales reached 32.116 million units, a year-on-year increase of 40.2%.
7. Xintian Green Energy (00956.HK): Total power generation in the first two months reached 3.0941 million MWh, an increase of 5.60% year-on-year.
8. Yue Yuen Group (00551.HK) announced its 2025 results: Profit attributable to owners of the company is approximately US$381 million, a decrease of 2.9% year-on-year.
9. Tian An (00028.HK) issued a profit warning: Annual profit attributable to shareholders is expected to be between HK$1.65 billion and HK$1.85 billion, turning a loss into a profit year-on-year.
10. Mobvista (01860.HK) released its 2025 annual results: Total revenue for the year reached US$2.047 billion, an increase of 35.7% year-on-year; adjusted EBITDA reached US$191 million, an increase of 38.1% year-on-year.
11. Times China Holdings (01233.HK): Contract sales (including sales from joint venture projects) in February amounted to approximately RMB105 million.
